Study on the biodegradability and biocompatibility of WE magnesium alloys

Abstract Magnesium alloys have been widely applied in biomedical devices because of their high strength, toughness, processing performance and the trace release of Mg 2 + . In this study, we investigated the biodegradability, cytocompatibility and hemocompatibility of four kinds of WE Mg alloys (where “W” indicates the metallic element Y and “E” represents mixed rare earth [RE] elements; Y: 2.5, 5.0, 6.5, and 7.5 wt.%; Nd: 1.0, 2.5, 2.6, and 4.2 wt.%; Zr: 0.8 wt.%) for their application in intravascular stent fabrication. The content of alloying elements affected not only mechanical properties of materials, but also their biocompatibility. We found that addition of RE elements could reduce the corrosion rates. Human umbilical vein endothelial cells (HUVECs) and vascular smooth muscle cells (VSMCs) were cultured in different extracts of WE Mg alloys. MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay was used to examine the cytotoxicity. The nitric oxide (NO) and lactate dehydrogenase (LDH) release were used to evaluate effects of Mg alloys on HUVECs. The addition of Y, Nd and Zr increased the cell viability and improved the hemocompatibility. Different alloy elements affected the morphology of samples, Mg 2 + release, and pH values in the medium. The results of mechanical properties, biocompatibility and biodegradability showed that Mg–5.0Y–2.6Nd–0.8Zr might be used as alternative materials of stent. However, it still needs to be further modified for clinical use. These findings suggest that selecting suitable alloying elements is particularly important.

[1]  Ke Yang,et al.  Effect of Y on the bio-corrosion behavior of extruded Mg–Zn–Mn alloy in Hank's solution , 2010 .

[2]  P. Lu,et al.  Controllable biodegradability, drug release behavior and hemocompatibility of PTX-eluting magnesium stents. , 2011, Colloids and surfaces. B, Biointerfaces.

[3]  S. Kashanian,et al.  Immobilisation of cobaltferritin onto gold electrode based on self-assembled monolayers. , 2012, IET nanobiotechnology.

[4]  Akiko Yamamoto,et al.  Effect of inorganic salts, amino acids and proteins on the degradation of pure magnesium in vitro , 2009 .

[5]  P. Uggowitzer,et al.  On the in vitro and in vivo degradation performance and biological response of new biodegradable Mg-Y-Zn alloys. , 2010, Acta biomaterialia.

[6]  Ke Yang,et al.  In vitro and in vivo evaluation of the surface bioactivity of a calcium phosphate coated magnesium alloy. , 2009, Biomaterials.

[7]  Raimund Erbel,et al.  Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents: a prospective, non-randomised multicentre trial , 2007, The Lancet.

[8]  Guixue Wang,et al.  The impact of vascular endothelial growth factor-transfected human endothelial cells on endothelialization and restenosis of stainless steel stents. , 2011, Journal of vascular surgery.

[9]  Yufeng Zheng,et al.  In vitro corrosion and biocompatibility of binary magnesium alloys. , 2009, Biomaterials.

[10]  Guixue Wang,et al.  Investigation of surface endothelialization on biomedical nitinol (NiTi) alloy: Effects of surface micropatterning combined with plasma nanocoatings. , 2009, Acta biomaterialia.

[11]  Xin Meng,et al.  The changes of oxidative stress and human 8-hydroxyguanine glycosylase1 gene expression in depressive patients with acute leukemia. , 2007, Leukemia research.

[12]  M. Leeflang,et al.  In vitro degradation behavior and cytocompatibility of Mg–Zn–Zr alloys , 2010, Journal of materials science. Materials in medicine.

[13]  Yingwei Song,et al.  Biodegradable behaviors of AZ31 magnesium alloy in simulated body fluid , 2009 .

[14]  Guixue Wang,et al.  Heparinized poly(vinyl alcohol)–small intestinal submucosa composite membrane for coronary covered stents , 2009, Biomedical materials.

[15]  Tadashi Kokubo,et al.  How useful is SBF in predicting in vivo bone bioactivity? , 2006, Biomaterials.

[16]  R. Guidoin,et al.  Biocompatibility study of plasma-coated nitinol (NiTi alloy) stents. , 2007, IET nanobiotechnology.

[17]  Bochu Wang,et al.  Protective effect of total flavonoids from Spirodela polyrrhiza (L.) Schleid on human umbilical vein endothelial cell damage induced by hydrogen peroxide. , 2007, Colloids and surfaces. B, Biointerfaces.

[18]  Qingsong Yu,et al.  A study on surface endothelialization of plasma coated intravascular stents , 2010 .

[19]  E. Tzeng,et al.  Nitric oxide and arterial disease. , 2004, Journal of vascular surgery.

[20]  R. Guidoin,et al.  Ultrasonic atomization and subsequent desolvation for monoclonal antibody (mAb) to the glycoprotein (GP) IIIa receptor into drug eluting stent. , 2009, Journal of microencapsulation.

[21]  Bernd Heublein,et al.  Preliminary Results after Application of Absorbable Metal Stents in Patients with Critical Limb Ischemia , 2005, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.

[22]  Ben Fabry,et al.  Control of magnesium corrosion and biocompatibility with biomimetic coatings. , 2011, Journal of biomedical materials research. Part B, Applied biomaterials.

[23]  Frank Witte,et al.  The history of biodegradable magnesium implants: a review. , 2010, Acta biomaterialia.

[24]  H. Haferkamp,et al.  In vivo corrosion of four magnesium alloys and the associated bone response. , 2005, Biomaterials.

[25]  A. Jovanovic,et al.  M-LDH physically associated with sarcolemmal KATP channels mediates cytoprotection in heart embryonic H9C2 cells , 2009, The international journal of biochemistry & cell biology.

[26]  D. Mantovani,et al.  Developments in metallic biodegradable stents. , 2010, Acta biomaterialia.

[27]  C. Gemmell,et al.  Platelet interactions with titanium: modulation of platelet activity by surface topography. , 2001, Biomaterials.

[28]  P. Erne,et al.  The Road to Bioabsorbable Stents: Reaching Clinical Reality? , 2006, CardioVascular and Interventional Radiology.

[29]  Guixue Wang,et al.  Review: Research Progress and Future Prospects for Promoting Endothelialization on Endovascular Stents and Preventing Restenosis , 2011 .

[30]  Yufeng Zheng,et al.  The development of binary Mg-Ca alloys for use as biodegradable materials within bone. , 2008, Biomaterials.

[31]  Michael Weyand,et al.  First successful implantation of a biodegradable metal stent into the left pulmonary artery of a preterm baby , 2005, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[32]  Ke Yang,et al.  Microstructure, mechanical properties and corrosion properties of Mg–Zn–Y alloys with low Zn content , 2008 .

[33]  Hui Chen,et al.  Adiponectin Stimulates Production of Nitric Oxide in Vascular Endothelial Cells* , 2003, Journal of Biological Chemistry.

[34]  A. Marx,et al.  Atheroprotective Effects of Neuronal Nitric Oxide Synthase in Apolipoprotein E Knockout Mice , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[35]  Jun Wang,et al.  Effect of Nd on the microstructure, mechanical properties and corrosion behavior of die-cast Mg-4Al-based alloy , 2008 .

[36]  Y. Estrin,et al.  Bio-corrosion of a magnesium alloy with different processing histories , 2008 .

[37]  M. Ürgen,et al.  Physical elution in phage display selection of inorganic-binding peptides , 2009 .

[38]  A Haverich,et al.  Left main coronary artery fistula exiting into the right atrium , 2003, Heart.

[39]  R. Walter,et al.  In-vitro degradation behaviour of WE54 magnesium alloy in simulated body fluid , 2011 .

[40]  R. Raman,et al.  In vitro degradation and mechanical integrity of calcium-containing magnesium alloys in modified-simulated body fluid. , 2008, Biomaterials.